rs2240307

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004655.4(AXIN2):​c.432T>C​(p.Ile144Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0201 in 1,613,946 control chromosomes in the GnomAD database, including 1,500 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.044 ( 317 hom., cov: 32)
Exomes 𝑓: 0.018 ( 1183 hom. )

Consequence

AXIN2
NM_004655.4 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: -0.117

Publications

18 publications found
Variant links:
Genes affected
AXIN2 (HGNC:904): (axin 2) The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. [provided by RefSeq, Jul 2008]
AXIN2 Gene-Disease associations (from GenCC):
  • oligodontia-cancer predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, Orphanet
  • tooth agenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • craniosynostosis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004655.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 17-65558189-A-G is Benign according to our data. Variant chr17-65558189-A-G is described in ClinVar as Benign. ClinVar VariationId is 259515.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.117 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.143 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004655.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AXIN2
NM_004655.4
MANE Select
c.432T>Cp.Ile144Ile
synonymous
Exon 2 of 11NP_004646.3Q9Y2T1
AXIN2
NM_001363813.1
c.432T>Cp.Ile144Ile
synonymous
Exon 2 of 10NP_001350742.1E7ES00

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AXIN2
ENST00000307078.10
TSL:1 MANE Select
c.432T>Cp.Ile144Ile
synonymous
Exon 2 of 11ENSP00000302625.5Q9Y2T1
AXIN2
ENST00000375702.5
TSL:1
c.432T>Cp.Ile144Ile
synonymous
Exon 1 of 9ENSP00000364854.5E7ES00
ENSG00000266076
ENST00000577662.1
TSL:2
n.*608T>C
non_coding_transcript_exon
Exon 4 of 7ENSP00000462418.1J3KSC3

Frequencies

GnomAD3 genomes
AF:
0.0434
AC:
6600
AN:
151936
Hom.:
307
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0732
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.110
Gnomad ASJ
AF:
0.00865
Gnomad EAS
AF:
0.152
Gnomad SAS
AF:
0.0481
Gnomad FIN
AF:
0.0372
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00562
Gnomad OTH
AF:
0.0292
GnomAD2 exomes
AF:
0.0445
AC:
11190
AN:
251492
AF XY:
0.0398
show subpopulations
Gnomad AFR exome
AF:
0.0722
Gnomad AMR exome
AF:
0.120
Gnomad ASJ exome
AF:
0.00744
Gnomad EAS exome
AF:
0.167
Gnomad FIN exome
AF:
0.0328
Gnomad NFE exome
AF:
0.00502
Gnomad OTH exome
AF:
0.0272
GnomAD4 exome
AF:
0.0177
AC:
25866
AN:
1461892
Hom.:
1183
Cov.:
31
AF XY:
0.0174
AC XY:
12688
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0759
AC:
2541
AN:
33480
American (AMR)
AF:
0.118
AC:
5278
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00738
AC:
193
AN:
26136
East Asian (EAS)
AF:
0.166
AC:
6607
AN:
39700
South Asian (SAS)
AF:
0.0398
AC:
3435
AN:
86258
European-Finnish (FIN)
AF:
0.0295
AC:
1575
AN:
53418
Middle Eastern (MID)
AF:
0.0147
AC:
85
AN:
5768
European-Non Finnish (NFE)
AF:
0.00436
AC:
4849
AN:
1112012
Other (OTH)
AF:
0.0216
AC:
1303
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1853
3706
5560
7413
9266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0436
AC:
6637
AN:
152054
Hom.:
317
Cov.:
32
AF XY:
0.0490
AC XY:
3641
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.0734
AC:
3042
AN:
41462
American (AMR)
AF:
0.111
AC:
1689
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00865
AC:
30
AN:
3470
East Asian (EAS)
AF:
0.152
AC:
787
AN:
5170
South Asian (SAS)
AF:
0.0482
AC:
231
AN:
4794
European-Finnish (FIN)
AF:
0.0372
AC:
394
AN:
10594
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00562
AC:
382
AN:
67968
Other (OTH)
AF:
0.0374
AC:
79
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
297
593
890
1186
1483
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0190
Hom.:
198
Bravo
AF:
0.0492
Asia WGS
AF:
0.0970
AC:
337
AN:
3478
EpiCase
AF:
0.00485
EpiControl
AF:
0.00516

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
5
Oligodontia-cancer predisposition syndrome (5)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
3
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
5.8
DANN
Benign
0.72
PhyloP100
-0.12
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2240307;
hg19: chr17-63554307;
COSMIC: COSV61056425;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.